- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
In 2006, has the EHR's time finally come?
The editors at CMP Healthcare Media have been watching development of the electronic health record for several years, waiting for a time when all the stars might align-technology, infrastructure, and interest from providers. That time may be upon us. One quarter of healthcare executives polled by HIMSS claim to have a functioning medical record in place, and another 36% are plunging ahead with plans of their own.
The editors at CMP Healthcare Media have been watching development of the electronic health record for several years, waiting for a time when all the stars might align-technology, infrastructure, and interest from providers. That time may be upon us. One quarter of healthcare executives polled by HIMSS claim to have a functioning medical record in place, and another 36% are plunging ahead with plans of their own.
What exactly an EHR is may still be subject to debate, but standards for data sharing and integration are quickly breaking down barriers among departments and silos of information. As business editor Greg Freiherr notes in his article on page S-12, these standards should allow health entities to become more fully integrated, whether they rely on a single vendor platform or connect multiple systems. The result will expose radiology's output, and the specialty's value in the clinical process, more completely to the rest of the clinical team.
Look for Diagnostic Imaging to cover this evolution in practice in the months and years ahead, including the changes in standards and technology as well as the effect that an ever-growing volume of data has on the clinical care process.
-Jane Lowers is special projects editor for Diagnostic Imaging
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
